A detailed history of First Hawaiian Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, First Hawaiian Bank holds 17,088 shares of NVO stock, worth $1.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,088
Previous 9,186 86.02%
Holding current value
$1.5 Million
Previous $1.31 Million 55.15%
% of portfolio
0.07%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$119.07 - $145.42 $940,891 - $1.15 Million
7,902 Added 86.02%
17,088 $2.03 Million
Q2 2024

Jul 02, 2024

SELL
$122.71 - $146.91 $1.07 Million - $1.28 Million
-8,742 Reduced 48.76%
9,186 $1.31 Million
Q1 2024

Apr 05, 2024

SELL
$102.11 - $135.92 $41,865 - $55,727
-410 Reduced 2.24%
17,928 $2.3 Million
Q4 2023

Jan 08, 2024

BUY
$87.78 - $105.45 $739,370 - $888,205
8,423 Added 84.95%
18,338 $1.9 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $532,999 - $1.17 Million
5,861 Added 144.57%
9,915 $901,000
Q2 2023

Jul 06, 2023

BUY
$155.98 - $172.65 $158,163 - $175,067
1,014 Added 33.36%
4,054 $656,000
Q1 2023

Apr 18, 2023

BUY
$132.34 - $159.14 $96,872 - $116,490
732 Added 31.72%
3,040 $483,000
Q4 2022

Jan 12, 2023

SELL
$102.55 - $135.33 $69,221 - $91,347
-675 Reduced 22.63%
2,308 $312,000
Q3 2022

Oct 05, 2022

SELL
$95.28 - $116.93 $3,525 - $4,326
-37 Reduced 1.23%
2,983 $297,000
Q2 2022

Jul 22, 2022

BUY
$103.24 - $121.81 $67,312 - $79,420
652 Added 27.53%
3,020 $336,000
Q1 2022

Apr 06, 2022

BUY
$93.1 - $112.54 $34,074 - $41,189
366 Added 18.28%
2,368 $263,000
Q4 2021

Jan 12, 2022

BUY
$95.88 - $117.08 $191,951 - $234,394
2,002 New
2,002 $224,000
Q1 2020

Apr 21, 2020

SELL
$49.46 - $64.78 $761,486 - $997,352
-15,396 Closed
0 $0
Q4 2019

Jan 13, 2020

SELL
$49.86 - $58.26 $381,827 - $446,155
-7,658 Reduced 33.22%
15,396 $891,000
Q3 2019

Oct 03, 2019

SELL
$47.54 - $53.43 $54,718 - $61,497
-1,151 Reduced 4.76%
23,054 $1.19 Million
Q2 2019

Jul 15, 2019

SELL
$46.79 - $52.47 $47,912 - $53,729
-1,024 Reduced 4.06%
24,205 $1.24 Million
Q1 2019

Apr 02, 2019

SELL
$46.36 - $52.63 $460,493 - $522,773
-9,933 Reduced 28.25%
25,229 $1.32 Million
Q4 2018

Jan 11, 2019

BUY
$41.54 - $47.25 $61,562 - $70,024
1,482 Added 4.4%
35,162 $1.62 Million
Q3 2018

Oct 16, 2018

BUY
$46.76 - $51.24 $1.57 Million - $1.73 Million
33,680 New
33,680 $1.59 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.